EUVIMEDEUVIMED entdecken
Crossref

Multi-omics analysis reveals dynamic proteomic remodeling and metabonomic dysregulation underlying cytokine release syndrome in CAR-T-treated B-ALL

Xueting Ren, Yue Zhou, Wenli Deng, Yanli Feng, Junjie Gou, Feng Guan, Xiang Li, Zengqi Tan, Yi Wang

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Xueting Ren und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Provincial People's Hospital, Xi'an, China; The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Cytokine Release Syndrome, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CAR-T therapy has transformed B-cell acute lymphoblastic leukemia (B-ALL) treatment, but predictive biomarkers for efficacy and toxicity remain limited. Through liquid chromatography-tandem mass spectrometry (LC-MS/MS) profiling of 19 B-ALL patients across four treatment phases. Proteomic analysis revealed dynamic alterations in immune response, inflammatory regulation, complement activation, and cellular metabolism during treatment. Cytokine release syndrome (CRS)-associated differentially expressed proteins predominantly involved complement and coagulation cascades, cell adhesion molecules, and phagosome pathways. Metabonomic profiling demonstrated enrichment in taurine and hypotaurine metabolism, primary bile acid biosynthesis, and steroid hormone biosynthesis pathways during CAR-T therapy. Stage-specific metabolites of CRS revealed escalating arginine and proline metabolism dysregulation and nicotinate-nicotinamide metabolism activation, correlating with inflammatory escalation and multi-organ injury. Cox regression analysis was used to screen 6 protein [(SCRN2, OAF, SBSN, ERP44, TWF2 and ENSA) and 7 metabolic (pseudouridine, 3-methylglutarylcarnitine, 3-(2-hydroxyphenyl) propanoic acid, N-acetylthreonine, PC(18:1(9Z)/16:0), PE(P-18:0/20:4(5Z,8Z,11Z,14Z)), and Cer(d18:1/24:1(15Z)] markers, which showed good predictive ability and provided potential biomarkers for CRS monitoring and survival prediction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytokine Release SyndromePrecursor Cell Lymphoblastic Leukemia-LymphomaHumansProteomicsMetabolomicsMaleFemaleAdultChildAdolescentYoung AdultCytokinesTandem Mass SpectrometryChild, PreschoolProteomeMiddle AgedMultiomics

Stichwörter der Autor:innen

B-ALLCAR-TCRSmetabonomicsproteomics

Substanzen

CytokinesProteome

Autor:innen und Institutionen

  • Department of Hematology, Provincial People's Hospital, Xi'an, China; The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi'an, China.
  • Department of Hematology, Provincial People's Hospital, Xi'an, China.
  • Institute of Hematology, Provincial Key Laboratory of Biotechnology, School of Medicine, Northwest University, Xi'an, China.
  • Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi'an, China. Electronic address: zengqtan@nwu.edu.cn.
  • Department of Hematology, Provincial People's Hospital, Xi'an, China. Electronic address: 13571936193@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ren, X., Zhou, Y., Deng, W., Feng, Y., Gou, J., Guan, F., Li, X., Tan, Z., & Wang, Y. (2025). Multi-omics analysis reveals dynamic proteomic remodeling and metabonomic dysregulation underlying cytokine release syndrome in CAR-T-treated B-ALL. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115690

Vancouver

Ren X, Zhou Y, Deng W, Feng Y, Gou J, Guan F, et al. Multi-omics analysis reveals dynamic proteomic remodeling and metabonomic dysregulation underlying cytokine release syndrome in CAR-T-treated B-ALL. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115690

BibTeX
@article{Ren2025,
  author = {Ren, Xueting and Zhou, Yue and Deng, Wenli and Feng, Yanli and Gou, Junjie and Guan, Feng and Li, Xiang and Tan, Zengqi and Wang, Yi},
  title = {Multi-omics analysis reveals dynamic proteomic remodeling and metabonomic dysregulation underlying cytokine release syndrome in CAR-T-treated B-ALL},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115690}
}
Kostenlos starten →